The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
RET revisited: expanding the oncogenic portfolio
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Esposito, C. L., D’Alessio, A., de Franciscis, V., & Cerchia, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001643 · Cited by 49
RetractedComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Neuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Self-citationThe GDNF family: Signalling, biological functions and therapeutic value
Airaksinen, M. S., & Saarma, M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn812 · Cited by 1,828
Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., & Pachnis, V. (1994) · Nature · doi:10.1038/367380a0 · Cited by 1,614
Wells, S. A., Robinson, B. G., Gagel, R. F., Dralle, H., Fagin, J. A., Santoro, M., Baudin, E., Elisei, R., Jarzab, B., Vasselli, J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5040 · Cited by 1,559
Molecular pathogenesis and mechanisms of thyroid cancer
Xing, M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3431 · Cited by 1,426
Regulation of Cell Fate Decision of Undifferentiated Spermatogonia by GDNF
Meng, X., Lindahl, M., Hyvönen, M. E., Parvinen, M., de Rooij, D. G., Hess, M. W., Raatikainen-Ahokas, A., Sainio, K., Rauvala, H., Lakso, M., et al. (2000) · Science · doi:10.1126/science.287.5457.1489 · Cited by 1,404
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Kloos (Chair), R. T., Eng, C., Evans, D. B., Francis, G. L., Gagel, R. F., Gharib, H., Moley, J. F., Pacini, F., Ringel, M. D., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0403 · Cited by 1,357
RET, ROS1 and ALK fusions in lung cancer
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2658 · Cited by 1,320
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P., & Wells, S. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.851 · Cited by 1,303
Cabozantinib in Progressive Medullary Thyroid Cancer
Elisei, R., Schlumberger, M. J., Müller, S. P., Schöffski, P., Brose, M. S., Shah, M. H., Licitra, L., Jarzab, B., Medvedev, V., Kreissl, M. C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4659 · Cited by 1,217
Hirschsprung disease, associated syndromes and genetics: a review
Amiel, J., Sproat-Emison, E., Garcia-Barcelo, M., Lantieri, F., Burzynski, G., Borrego, S., Pelet, A., Arnold, S., Miao, X., Griseri, P., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.053959 · Cited by 1,206
Hofstra, R. M. W., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., Pasini, B., Hoppener, J. W. M., van Amstel, H. K. P., Romeo, G., et al. (1994) · Nature · doi:10.1038/367375a0 · Cited by 1,149
Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Ports, G., Fusco, A., & Vecchiot, G. (1990) · Cell · doi:10.1016/0092-8674(90)90659-3 · Cited by 959
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
Songyang, Z., Carraway, K. L., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., et al. (1995) · Nature · doi:10.1038/373536a0 · Cited by 919
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Lipson, D., Capelletti, M., Yelensky, R., Otto, G., Parker, A., Jarosz, M., Curran, J. A., Balasubramanian, S., Bloom, T., Brennan, K. W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2673 · Cited by 869
Expression of the c-ret proto-oncogene during mouse embryogenesis
Pachnis, V., Mankoo, B., & Costantini, F. (1993) · Development · doi:10.1242/dev.119.4.1005 · Cited by 837
KIF5B-RET fusions in lung adenocarcinoma
Kohno, T., Ichikawa, H., Totoki, Y., Yasuda, K., Hiramoto, M., Nammo, T., Sakamoto, H., Tsuta, K., Furuta, K., Shimada, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2644 · Cited by 834
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
Mulligan, L. M., Eng, C., Healey, C. S., Clayton, D., Kwok, J. B. J., Gardner, E., Ponder, M. A., Frilling, A., Jackson, C. E., Lehnert, H., et al. (1994) · Nature Genetics · doi:10.1038/ng0194-70 · Cited by 652
Self-citationKurzrock, R., Sherman, S. I., Ball, D. W., Forastiere, A. A., Cohen, R. B., Mehra, R., Pfister, D. G., Cohen, E. E. W., Janisch, L., Nauling, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.4145 · Cited by 550
RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
Wang, R., Hu, H., Pan, Y., Li, Y., Ye, T., Li, C., Luo, X., Wang, L., Li, H., Zhang, Y., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.1477 · Cited by 546
Proximity of Chromosomal Loci That Participate in Radiation-Induced Rearrangements in Human Cells
Nikiforova, M. N., Stringer, J. R., Blough, R., Medvedovic, M., Fagin, J. A., & Nikiforov, Y. E. (2000) · Science · doi:10.1126/science.290.5489.138 · Cited by 468
RET tyrosine kinase signaling in development and cancer
Arighi, E., Borrello, M. G., & Sariola, H. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.010 · Cited by 468
Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
Drilon, A., Wang, L., Hasanovic, A., Suehara, Y., Lipson, D., Stephens, P., Ross, J., Miller, V., Ginsberg, M., Zakowski, M. F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0035 · Cited by 464
A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk
Emison, E. S., McCallion, A. S., Kashuk, C. S., Bush, R. T., Grice, E., Lin, S., Portnoy, M. E., Cutler, D. J., Green, E. D., & Chakravarti, A. (2005) · Nature · doi:10.1038/nature03467 · Cited by 462
Takahashi, M., Buma, Y., Iwamoto, T., Inaguma, Y., Ikeda, H., & Hiai, H. (1988) · PubMed · Cited by 442
Durbec, P. L., Larsson-Blomberg, L. B., Schuchardt, A., Costantini, F., & Pachnis, V. (1996) · Development · doi:10.1242/dev.122.1.349 · Cited by 418
Naughton, C. K., Jain, S., Strickland, A. M., Gupta, A., & Milbrandt, J. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.105.047365 · Cited by 390
Enteric nervous system development: migration, differentiation, and disease
Lake, J. I., & Heuckeroth, R. O. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00452.2012 · Cited by 382
Mechanism of Activation of the ret Proto-oncogene by Multiple Endocrine Neoplasia 2A Mutations
Asai, N., Iwashita, T., Matsuyama, M., & Takahashi, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1613 · Cited by 340
Bounacer, A., Wicker, R., Caillou, B., Cailleux, A. F., Sarasin, A., Schlumberger, M., & Suárez, H. G. (1997) · Oncogene · doi:10.1038/sj.onc.1200206 · Cited by 339
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
Wells, S. A., Pacini, F., Robinson, B. G., & Santoro, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1204 · Cited by 338
Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
Dar, A. C., Das, T. K., Shokat, K. M., & Cagan, R. L. (2012) · Nature · doi:10.1038/nature11127 · Cited by 333
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
Borrello, M. G., Alberti, L., Fischer, A., Degl'Innocenti, D., Ferrario, C., Gariboldi, M., Marchesi, F., Allavena, P., Greco, A., Collini, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503039102 · Cited by 331
Schuchardt, A., D’Agati, V., Pachnis, V., & Costantini, F. (1996) · Development · doi:10.1242/dev.122.6.1919 · Cited by 318
Tansey, M. G., Baloh, R. H., Milbrandt, J., & Johnson, E. M. (2000) · Neuron · doi:10.1016/s0896-6273(00)81064-8 · Cited by 308
Structure and Chemical Inhibition of the RET Tyrosine Kinase Domain
Knowles, P. P., Murray-Rust, J., Kjær, S., Scott, R. P., Hanrahan, S., Santoro, M., Ibáñez, C. F., & McDonald, N. Q. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605604200 · Cited by 302
Kohlmann, A., Grossmann, V., Klein, H.-U., Schindela, S., Weiss, T., Kazak, B., Dicker, F., Schnittger, S., Dugas, M., Kern, W., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1361 · Cited by 299
Tyrosine kinase receptor RET is a key regulator of Peyer’s Patch organogenesis
Veiga-Fernandes, H., Coles, M. C., Foster, K. E., Patel, A., Williams, A., Natarajan, D., Barlow, A., Pachnis, V., & Kioussis, D. (2007) · Nature · doi:10.1038/nature05597 · Cited by 285
Hwang, D.-Y., Dworschak, G. C., Kohl, S., Saisawat, P., Vivante, A., Hilger, A. C., Reutter, H. M., Soliman, N. A., Bogdanovic, R., Kehinde, E. O., et al. (2014) · Kidney International · doi:10.1038/ki.2013.508 · Cited by 263
Carlomagno, F., Guida, T., Anaganti, S., Vecchio, G., Fusco, A., Ryan, A. J., Billaud, M., & Santoro, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207810 · Cited by 258
Besset, V., Scott, R. P., & Ibáñez, C. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006908200 · Cited by 255
Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis
de Graaff, E., Srinivas, S., Kilkenny, C., D'Agati, V., Mankoo, B. S., Costantini, F., & Pachnis, V. (2001) · Genes & Development · doi:10.1101/gad.205001 · Cited by 251
Paracrine Regulation of Pancreatic Cancer Cell Invasion by Peripheral Nerves
Gil, Z., Cavel, O., Kelly, K., Brader, P., Rein, A., Gao, S. P., Carlson, D. L., Shah, J. P., Fong, Y., & Wong, R. J. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp456 · Cited by 237
Chi, X., Michos, O., Shakya, R., Riccio, P., Enomoto, H., Licht, J. D., Asai, N., Takahashi, M., Ohgami, N., Kato, M., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.07.013 · Cited by 233
Parent-of-origin effects in multiple endocrine neoplasia type 2B.
Carlson, K. M., Bracamontes, J. R., Jackson, C. E., Clark, R., Lacroix, A., Wells, S. A., & Goodfellow, P. J. (1994) · PubMed Central · Cited by 229
Berndt, I., Reuter, M., Saller, B., Frank-Raue, K., Groth, P., Grußendorf, M., Raue, F., Ritter, M. M., & Höppner, W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4619 · Cited by 229
Tsuzuki, T., Takahashi, M., Asai, N., Iwashita, T., Matsuyama, M., & Asai, J. (1995) · PubMed · Cited by 225
Segouffin-Cariou, C., & Billaud, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3568 · Cited by 223
Hayashi, H., Ichihara, M., Iwashita, T., Murakami, H., Shimono, Y., Kawai, K., Kurokawa, K., Murakumo, Y., Imai, T., Funahashi, H., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203799 · Cited by 223
Kramer, E. R., Aron, L., Ramakers, G. M. J., Seitz, S., Zhuang, X., Beyer, K., Smidt, M. P., & Klein, R. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050039 · Cited by 209
Renal Aplasia in Humans Is Associated with RET Mutations
Skinner, M. A., Safford, S. D., Reeves, J. G., Jackson, M. E., & Freemerman, A. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.008 · Cited by 199
GDNF and GFRα: a versatile molecular complex for developing neurons
Paratcha, G., & Ledda, F. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.05.003 · Cited by 198
Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer
Lang, D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg107 · Cited by 187
Cavel, O., Shomron, O., Shabtay, A., Vital, J., Trejo-Leider, L., Weizman, N., Krelin, Y., Fong, Y., Wong, R. J., Amit, M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0764 · Cited by 183
Structure and Physiology of the RET Receptor Tyrosine Kinase
Ibanez, C. F. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009134 · Cited by 183
Tahira, T., Ishizaka, Y., Itoh, F., Sügimura, T., & Nagao, M. (1990) · PubMed · Cited by 180
RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
Romei, C., & Elisei, R. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00054 · Cited by 176
Critical and distinct roles for key RET tyrosine docking sites in renal development
Jain, S., Encinas, M., Johnson, E. M., & Milbrandt, J. (2006) · Genes & Development · doi:10.1101/gad.1387206 · Cited by 165
Anders, J., Kjær, S., & Ibáñez, C. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104968200 · Cited by 163
Ret Is a Multifunctional Coreceptor that Integrates Diffusible- and Contact-Axon Guidance Signals
Bonanomi, D., Chivatakarn, O., Bai, G., Abdesselem, H., Lettieri, K., Marquardt, T., Pierchala, B. A., & Pfaff, S. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.024 · Cited by 161
Hamatani, K., Eguchi, H., Ito, R., Mukai, M., Takahashi, K., Taga, M., Imai, K., Cologne, J., Soda, M., Arihiro, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0293 · Cited by 160
Frank‐Raue, K., Rybicki, L. A., Erlic, Z., Schweizer, H., Winter, A., Milos, I., Toledo, S. P. A., Toledo, R. A., Tavares, M. R., Alevizaki, M. K., et al. (2010) · Human Mutation · doi:10.1002/humu.21385 · Cited by 150
Plaza-Menacho, I., Morandi, A., Robertson, D. M., Pancholi, S., Drury, S., Dowsett, M., Martin, L.-A., & Isacke, C. M. (2010) · Oncogene · doi:10.1038/onc.2010.209 · Cited by 149
Frequent association between MEN 2A and cutaneous lichen amyloidosis
Verga, U., Fugazzola, L., Cambiaghi, S., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01782.x · Cited by 145
Multikinase inhibitors: a new option for the treatment of thyroid cancer
Gild, M. L., Bullock, M., Robinson, B. G., & Clifton-Bligh, R. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.141 · Cited by 140
Frequency of RET mutations in long- and short-segment Hirschsprung disease
Seri, M., Yin, L., Barone, V., Bolino, A., Celli, I., Bocciardi, R., Pasini, B., Ceccherini, I., Lerone, M., Kristoffersson, U., et al. (1997) · Human Mutation · Cited by 139
Novel Mechanism of Regulation of Rac Activity and Lamellipodia Formation by RET Tyrosine Kinase
Fukuda, T., Kiuchi, K., & Takahashi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200643200 · Cited by 134
Synergistic Effects of GDNF and VEGF on Lifespan and Disease Progression in a Familial ALS Rat Model
Krakora, D., Mulcrone, P. L., Meyer, M., Lewis, C. M., Bernau, K., Gowing, G., Zimprich, C., Aebischer, P., Svendsen, C. N., & Suzuki, M. (2013) · Molecular Therapy · doi:10.1038/mt.2013.108 · Cited by 133
Tsui-Pierchala, B. A., Milbrandt, J., & Johnson, E. (2002) · Neuron · doi:10.1016/s0896-6273(01)00585-2 · Cited by 133
Camós, M., Esteve, J., Jares, P., Colomer, D., Rozman, M., Villamor, N., Costa, D., Carrió, A., Nomdedeu, J. F., Montserrat, E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4601 · Cited by 129
Coordinated Activation of Autophosphorylation Sites in the RET Receptor Tyrosine Kinase
Coulpier, M., Anders, J., & Ibáñez, C. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107992200 · Cited by 128
Boulay, A., Breuleux, M., Stephan, C., Fux, C., Brisken, C., Fiche, M., Wartmann, M., Stumm, M., Lane, H. A., & Hynes, N. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5100 · Cited by 123
Developmental expression of the RET protooncogene.
Avantaggiato, V., Dathan, N. A., Grieco, M., Fabien, N., Lazzaro, D., Fusco, A., Simeone, A., & Santoro, M. (1994) · PubMed · Cited by 120
Morandi, A., Martin, L., Gao, Q., Pancholi, S., Mackay, A. G., Robertson, D. M., Zvelebil, M., Dowsett, M., Plaza-Menacho, I., & Isacke, C. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4265 · Cited by 120
Iwashita, T., Kato, M., Murakami, H., Asai, N., Ishiguro, Y., Ito, S., Iwata, Y., Kawai, K., Asai, M., Kurokawa, K., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202742 · Cited by 120
Gattei, V., Degan, M., Gloghini, A., Iuliis, A. D., Improta, S., Rossi, F. M., Aldinucci, D., Perin, V., Serraino, D., Babare, R., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2048 · Cited by 117
Leeman‐Neill, R. J., Brenner, A. V., Little, M. P., et al. (2013) · Cancer · doi:10.1002/cncr.27893 · Cited by 116
Tyrosine 981, a Novel Ret Autophosphorylation Site, Binds c-Src to Mediate Neuronal Survival
Encinas, M., Crowder, R. J., Milbrandt, J., & Johnson, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400505200 · Cited by 113
RET is a potential tumor suppressor gene in colorectal cancer
Luo, Y., Tsuchiya, K. D., Park, D. I., Fausel, R. A., Kanngurn, S., Welcsh, P. L., Dzieciatkowski, S., Wang, J., & Grady, W. M. (2012) · Oncogene · doi:10.1038/onc.2012.225 · Cited by 110
Evolution of the GDNF Family Ligands and Receptors
Airaksinen, M. S., Holm, L., & Hätinen, T. (2006) · Brain Behavior and Evolution · doi:10.1159/000094087 · Cited by 107
MEN2A-RET-induced cellular transformation by activation of STAT3
Schuringa, J. J., Wojtachnio, K., Hagens, W. I., Vellenga, E., Buys, C. H. C. M., Hofstra, R. M. W., & Kruijer, W. (2001) · Oncogene · doi:10.1038/sj.onc.1204715 · Cited by 106
Differential RET Signaling Pathways Drive Development of the Enteric Lymphoid and Nervous Systems
Patel, A. J., Harker, N., Moreira-Santos, L., Ferreira, M. M., Alden, K., Timmis, J., Foster, K., Garefalaki, A., Pachnis, P., Andrews, P. S., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002734 · Cited by 106
RET Is Dispensable for Maintenance of Midbrain Dopaminergic Neurons in Adult Mice
Jain, S. R., Golden, J. P., Wozniak, D. F., Pehek, E. A., Johnson, E. M., & Milbrandt, J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1876-06.2006 · Cited by 106
Pheochromocytoma penetrance varies by RET mutation in MEN 2A
Quayle, F. J., Fialkowski, E., Benveniste, R. J., & Moley, J. F. (2007) · Surgery · doi:10.1016/j.surg.2007.09.013 · Cited by 103
Ballerini, P. F., Struski, S., Cresson, C., Prade, N., Toujani, S., Deswarte, C., Dobbelstein, S., Petit, A., Lapillonne, H., Gautier, E., et al. (2012) · Leukemia · doi:10.1038/leu.2012.109 · Cited by 101
Asai, N., Fukuda, T., Wu, Z., Enomoto, A., Pachnis, V., Takahashi, M., & Costantini, F. D. (2006) · Development · doi:10.1242/dev.02616 · Cited by 98
Vita, G. D., Melillo, R. M., Carlomagno, F., Visconti, R., Castellone, M. D., Bellacosa, A., Billaud, M., Fusco, A., Tsichlis, P. N., & Santoro, M. M. (2000) · PubMed · Cited by 96
Chatterjee, R., Ramos, E., Hoffman, M., VanWinkle, J., Martin, D. R., Davis, T. K., Hoshi, M., Hmiel, S. P., Beck, A., Hruska, K. A., et al. (2012) · Human Genetics · doi:10.1007/s00439-012-1181-3 · Cited by 96
Falco, V. D., Buonocore, P., Muthu, M., Torregrossa, L., Basolo, F., Billaud, M., Gozgit, J. M., Carlomagno, F., & Santoro, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2672 · Cited by 96
Surgical Curability of Medullary Thyroid Cancer in Multiple Endocrine Neoplasia 2B
Brauckhoff, M., Machens, A., Lorenz, K., Bjøro, T., Varhaug, J. E., & Dralle, H. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a6f43a · Cited by 95
Plaza-Menacho, I., Koster, R., van der Sloot, A. M., Quax, W. J., Osinga, J., van der Sluis, T., Hollema, H., Burzynski, G. M., Gimm, O., Buys, C. H. C. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2363 · Cited by 94
Gattelli, A., Nalvarte, I., Boulay, A., Roloff, T. C., Schreiber, M., Carragher, N. O., Macleod, K., Schlederer, M., Lienhard, S., Kenner, L., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302625 · Cited by 92
Takahashi, M., Iwashita, T., Santoro, M. M., Lyonnet, S., Lenoir, G., & Billaud, M. (1999) · Human Mutation · Cited by 91
Jijiwa, M., Kawai, K., Fukihara, J., Nakamura, A., Hasegawa, M., Suzuki, C., Sato, T., Enomoto, A., Asai, N., Murakumo, Y., et al. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01171.x · Cited by 91
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years
Romei, C., Fugazzola, L., Puxeddu, E., Frasca, F., Viola, D., Muzza, M., Moretti, S., Nicolosi, M. L., Giani, C., Cirello, V., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1269 · Cited by 90
Wong, A. L., Bogni, S., Kotka, P., de Graaff, E., D’Agati, V. D., Costantini, F. D., & Pachnis, V. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9661-9673.2005 · Cited by 89
Ito, Y., Okada, Y., Sato, M., Sawai, H., Funahashi, H., Murase, T., Hayakawa, T., & Manabe, T. (2005) · Surgery · doi:10.1016/j.surg.2005.07.007 · Cited by 89
Carhill, A. A., Cabanillas, M. E., Jiménez, C., Waguespack, S. G., Habra, M. A., Hu, M. I.-N., Ying, A. K., Vassilopoulou‐Sellin, R., Gagel, R. F., Sherman, S. I., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2909 · Cited by 88
RET Signaling Is Required for Survival and Normal Function of Nonpeptidergic Nociceptors
Golden, J. P., Hoshi, M., Nassar, M. A., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5930-09.2010 · Cited by 88
Castellone, M. D., Falco, V. D., Rao, D. M., Bellelli, R., Muthu, M., Basolo, F., Fusco, A., Gutkind, J. S., & Santoro, M. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1982 · Cited by 88
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase
Mologni, L., Redaelli, S., Morandi, A., Plaza-Menacho, I., & Gambacorti-Passerini, C. B. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.025 · Cited by 87
Artemin is oncogenic for human mammary carcinoma cells
Kang, J., Perry, J. K., Pandey, V., Fielder, G. C., Mei, B., Qian, P., Wu, Z. S., Zhu, T., Liu, D., & Lobie, P. E. (2009) · Oncogene · doi:10.1038/onc.2009.66 · Cited by 87
GDNF — A potential target to treat addiction
Carnicella, S., & Dorit Ron, A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.12.001 · Cited by 85
Li, F., Feng, Y., Fang, R., Fang, Z., Xia, J., Han, X., Liu, X., Chen, H., Liu, H., & Ji, H. (2012) · Cell Research · doi:10.1038/cr.2012.27 · Cited by 79
Erlic, Z., Hoffmann, M. M., Sullivan, M., Franke, G., Pęczkowska, M., Harsch, I. A., Schott, M., Gabbert, H. E., Välimäki, M. J., Preuss, S. F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1728 · Cited by 77
Jasim, S., Ying, A. K., Waguespack, S. G., et al. (2010) · Thyroid · doi:10.1089/thy.2010.0328 · Cited by 77
Schuetz, G., Rosário, M., Grimm, J., Boeckers, T. M., Gundelfinger, E. D., & Birchmeier, W. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404108 · Cited by 76
Wang, X. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.10.008 · Cited by 75
The many faces of RET dysfunction in kidney
Jain, S. R. (2009) · Organogenesis · doi:10.4161/org.5.4.10048 · Cited by 75
Choi, S., Yoon, S., Calabrese, P. P., & Arnheim, N. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002420 · Cited by 73
A Novel RET Kinase–β-Catenin Signaling Pathway Contributes to Tumorigenesis in Thyroid Carcinoma
Gujral, T. S., van Veelen, W., Richardson, D. S., Myers, S. M., Meens, J., Acton, D. S., Duñach, M., Elliott, B. E., Höppener, J. W. M., & Mulligan, L. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6052 · Cited by 72
Self-citationBrose, M. S., Nutting, C. M., Jarząb, B., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.4 · Cited by 70
Plaza-Menacho, I., van der Sluis, T., Hollema, H., Gimm, O., Buys, C. H. C. M., Magee, A. I., Isacke, C. M., Hofstra, R. M. W., & Eggen, B. J. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608952200 · Cited by 68
Jeanpierre, C., Macé, G., Parisot, M., Morinière, V., Pawtowski, A., Benabou, M., Martinovic, J., Amiel, J., Attié‐Bitach, T., Delezoide, A., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.088526 · Cited by 68
Cosci, B., Vivaldi, A., Romei, C., Gemignani, F., Landi, S., Ciampi, R., Tacito, A., Molinaro, E., Agate, L., Bottici, V., et al. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0117 · Cited by 67
Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells
Gild, M. L., Landa, I., Ryder, M. M., Ghossein, R. A., Knauf, J. A., & Fagin, J. A. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0085 · Cited by 65
Alternative splicing results in RET isoforms with distinct trafficking properties
Richardson, D. S., Rodrigues, D. M., Hyndman, B. D., Crupi, M. J. F., Nicolescu, A. C., & Mulligan, L. M. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0114 · Cited by 64
Self-citationTranscriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3
Leon, T. Y. Y., Ngan, E., Poon, H.-C., So, M., Lui, V. C. H., Tam, P. K. H., & Garcia-Barcelo, M. M. (2009) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2008.11.055 · Cited by 63
The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation
Peterson, S., & Bogenmann, E. (2004) · Oncogene · doi:10.1038/sj.onc.1206980 · Cited by 63
Plaza-Menacho, I., Morandi, A., Mologni, L., Boender, P. J., Gambacorti-Passerini, C. B., Magee, A. I., Hofstra, R. M. W., Knowles, P. P., McDonald, N. Q., & Isacke, C. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168500 · Cited by 63
Aron, L., Klein, P., Pham, T.-T., Kramer, E. R., Wurst, W., & Klein, R. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000349 · Cited by 61
Conservation of RET proto-oncogene splicing variants and implications for RET isoform function
Carter, M. T., Yome, J. L., Marcil, M. N., Martin, C. A., Vanhorne, J. B., & Mulligan, L. M. (2001) · Cytogenetic and Genome Research · doi:10.1159/000059341 · Cited by 58
Self-citationPhosphorylation of protocadherin proteins by the receptor tyrosine kinase Ret
Schalm, S. S., Ballif, B. A., Buchanan, S. M., Phillips, G. R., & Maniatis, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007182107 · Cited by 57
Transcript Level Modulates the Inherent Oncogenicity of RET/PTC Oncoproteins
Richardson, D. S., Gujral, T. S., Peng, S. S., Asa, S. L., & Mulligan, L. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4425 · Cited by 56
Self-citationPerrinjaquet, M., Vilar, M., & Ibáñez, C. F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144923 · Cited by 53
Rusmini, M., Griseri, P., Lantieri, F., Matera, I., Hudspeth, K. L., Roberto, A., Mikulak, J., Avanzini, S., Rossi, V., Mattioli, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059066 · Cited by 53
Díaz‐Beyá, M., Navarro, A., Ferrer, G., Díaz, T., Gel, B., Camós, M., Pratcorona, M., Torrebadell, M., Rozman, M., Colomer, D., et al. (2012) · Leukemia · doi:10.1038/leu.2012.278 · Cited by 52
Growth Factors and Neuropathic Pain
Ossipov, M. H. (2011) · Current Pain and Headache Reports · doi:10.1007/s11916-011-0183-5 · Cited by 50
Brose, M. S., Nutting, C. M., Jarząb, B., Elisei, R., Siena, S., Bastholt, L., de la Fouchardière, C., Pacini, F., Paschke, R., Shong, Y. K., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.18_suppl.4 · Cited by 50
Crosstalk between VEGF-A/VEGFR2 and GDNF/RET signaling pathways
Tufró, A., Teichman, J., Banu, N., & Villegas, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.146 · Cited by 49
Gattei, V., Celetti, A., Cerrato, A., Degan, M., Iuliis, A. D., Rossi, F. M., Chiappetta, G., Consales, C., Improta, S., Zagonel, V., et al. (1997) · PubMed · doi:10.1182/blood.v89.8.2925 · Cited by 48
Ret-mediated mitogenesis requires Src kinase activity.
Melillo, R. M., Barone, M. V., Lupoli, G., Cirafici, A. M., Carlomagno, F., Visconti, R., Matoskova, B., Fiore, P. P. D., Vecchio, G., Fusco, A., et al. (1999) · PubMed · Cited by 48
Differential interaction of Enigma protein with the two RET isoforms
Borrello, M. G., Mercalli, E., Perego, C., Degl’Innocenti, D., Ghizzoni, S., Arighi, E., Eroini, B., Rizzetti, M. G., & Pierotti, M. A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00886-0 · Cited by 46
Yamaga, R., Ikeda, K., Horie‐Inoue, K., Ouchi, Y., Suzuki, Y., & Inoue, S. (2013) · Hormones and Cancer · doi:10.1007/s12672-013-0140-3 · Cited by 46
RET inhibition: implications in cancer therapy
Borrello, M. G., Ardini, E., Locati, L. D., Greco, A., Licitra, L. F., & Pierotti, M. A. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.758715 · Cited by 43
Miše, N., Drosten, M., Racek, T., Tannapfel, A., & Pützer, B. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209669 · Cited by 41
RET-Mediated Cell Adhesion and Migration Require Multiple Integrin Subunits
Cockburn, J., Richardson, D. S., Gujral, T. S., & Mulligan, L. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0771 · Cited by 38
Self-citationWang, C., Mayer, J. A., Mazumdar, A., & Brown, P. H. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1775-9 · Cited by 36
RET(MEN 2B) is active in the endoplasmic reticulum before reaching the cell surface
Runeberg‐Roos, P., Virtanen, H. T., & Saarma, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210591 · Cited by 34
Sherman, S. I. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.03.442 · Cited by 33
Nakayama, S., Iida, K., Tsuzuki, T., Iwashita, T., Murakami, H., Asai, N., Iwata, Y., Ichihara, M., Ito, S., Kawai, K., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01311.x · Cited by 31
Ryu, H., Jeon, G. S., Cashman, N. R., Kowall, N. W., & Lee, J.-H. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.203 · Cited by 30
DNA Topoisomerases Participate in Fragility of the Oncogene RET
Dillon, L. W., Pierce, L., Lehman, C. E., Nikiforov, Y. E., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075741 · Cited by 30
Lantieri, F., Caroli, F., Ceccherini, I., & Griseri, P. (2012) · International Journal of Cancer · doi:10.1002/ijc.27967 · Cited by 29
RET PLCγ Phosphotyrosine Binding Domain Regulates Ca2+ Signaling and Neocortical Neuronal Migration
Lundgren, K. C., Nakahata, K., Fritz, N., Rebellato, P., Zhang, S., & Uhlén, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031258 · Cited by 28
Díaz‐Rodriguez, E., García-Lavandeira, M., Pérez-Romero, S., Senra, A., Cañibano, C., Palmero, I., Borrello, M. G., Diéguez, C., & Álvarez, C. V. (2011) · Oncogene · doi:10.1038/onc.2011.458 · Cited by 24
Multiple Functional Effects of RET Kinase Domain Sequence Variants in Hirschsprung Disease
Hyndman, B. D., Gujral, T. S., Krieger, J. R., Cockburn, J., & Mulligan, L. M. (2012) · Human Mutation · doi:10.1002/humu.22170 · Cited by 24
Self-citationFunctional Role of the RET Dependence Receptor, GFRa Co-Receptors and Ligands in the Pituitary
García-Lavandeira, M., Díaz‐Rodriguez, E., García-Rendueles, M. E. R., Rodrigues, J. S., Pérez-Romero, S., Bravo, S. B., & Álvarez, C. V. (2010) · Frontiers of hormone research · doi:10.1159/000318502 · Cited by 23
Andrew, S. D., Capes‐Davis, A., Delhanty, P. J. D., Marsh, D. J., Mulligan, L. M., & Robinson, B. G. (2002) · Gene · doi:10.1016/s0378-1119(02)00919-8 · Cited by 21
Self-citationIs GDNF beneficial in Parkinson disease?
Hoffer, B. J., & Harvey, B. K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.149 · Cited by 21
Differential expression of the RET gene in human acute myeloid leukemia
Gattei, V., Degan, M., Aldinucci, D., Iuliis, A. D., Rossi, F. M., Mazzocco, F. T., Rupolo, M., Zagonel, V., & Pinto, A. (1998) · Annals of Hematology · doi:10.1007/s002770050444 · Cited by 14
Hirata, Y., Shimokawa, N., Oh‐hashi, K., Yu, Z., & Kiuchi, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06966.x · Cited by 10
Cited by
Antiangiogenic therapy in oncology: current status and future directions
Jayson, G. C., Kerbel, R., Ellis, L. M., & Harris, A. L. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01088-0 · Cited by 828
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
Drilon, A., Oxnard, G. R., Tan, D. S. W., Loong, H. H. F., Johnson, M., Gainor, J., McCoach, C. E., Gautschi, O., Besse, B., Cho, B. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2005653 · Cited by 828
Neuronal regulation of type 2 innate lymphoid cells via neuromedin U
Cardoso, V., Chesné, J., Ribeiro, H., García-Cassani, B., Carvalho, T., Bouchery, T., Shah, K., Barbosa-Morais, N. L., Harris, N., & Veiga-Fernandes, H. (2017) · Nature · doi:10.1038/nature23469 · Cited by 592
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
Zhao, Y., & Adjei, A. A. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0465 · Cited by 558
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Haddad, R. I., Bischoff, L., Ball, D., Bernet, V., Blomain, E., Busaidy, N. L., Campbell, M., Dickson, P., Duh, Q.-Y., Ehya, H., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0040 · Cited by 510
Metadata
- Authors
- Mulligan, L. M.
- Venue
- Nature Reviews Cancer
- Published
- 2014-02-24
- Volume
- 14
- Issue
- 3
- Pages
- 173-186
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2096735709
- Cited by
- 513
- References
- 159
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.